Humira is a prescription medication that belongs to a class of drugs known as TNF blockers. It is primarily used to treat various inflammatory conditions and autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis.
The active ingredient in Humira is adalimumab, which works by blocking the action of a protein called tumor necrosis factor-alpha (TNF-α) in the body. TNF-α is produced by the immune system and plays a key role in triggering inflammation. By inhibiting TNF-α, Humira helps to reduce inflammation, relieve symptoms, and prevent joint damage in arthritis patients, as well as control bowel inflammation in Crohn's disease and ulcerative colitis patients.
Humira is available in the form of a subcutaneous injection, and the dosing frequency and duration of treatment may vary depending on the condition being treated. It is usually administered by a healthcare professional or the patients themselves after proper training.
As with any medication, Humira may have potential side effects, including injection site reactions, respiratory infections, headaches, and stomach pain. It is important to consult with a healthcare provider for a proper diagnosis and to determine if Humira is the appropriate treatment option for a specific condition. Close monitoring and follow-up are necessary during its use.
